CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
Ji Sun Baek, Wan Ho Lee, Woo Dae Kang, Seok Mo Kim
Obstet Gynecol Sci. 2016;59(1):24-31.   Published online January 15, 2016
DOI: https://doi.org/10.5468/ogs.2016.59.1.24

Excel Download

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
Obstetrics & Gynecology Science. 2016;59(1):24   Crossref logo
Link1 Link2 Link3

Outcomes of fertility-sparing treatment with progestin in patients with early-stage endometrial cancer or severe atypical hyperplasia: Preliminary results of a phase II study in China
Gynecologic Oncology. 2015;137:91   Crossref logo
Link1 Link2

Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma
Fertility and Sterility. 2003;80(6):1315-1324   Crossref logo
Link1 Link2

Fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin
Gynecologic Oncology. 2013;130(1):e68-e69   Crossref logo
Link1 Link2

Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients
Gynecologic Oncology. 2015;139(3):424-428   Crossref logo
Link1 Link2

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin
Gynecologic Oncology. 2014;133(2):229-233   Crossref logo
Link1 Link2

Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer
Gynecologic Oncology. 2016;140(2):234-238   Crossref logo
Link1 Link2

Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium
Fertility and Sterility. 2009;92(6):2122-2124   Crossref logo
Link1 Link2

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis

Cancer Management and Research. 2019;Volume 11:4005-4021   Crossref logo
Link1 Link2

Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer
International Journal of Gynecology & Obstetrics. 2015;132(1):34-38   Crossref logo
Link1 Link2 Link3 Link4 Link5